Ticagrelor Tablet
Product Images NDC 43598-480

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Ticagrelor (NDC 43598-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1_90mg (Carton1 90mg)

The text describes Ticagrelor Tablets 90 mg, typically prescribed for adults. It includes instructions to refer to the package insert for the usual adult dosage, a warning to keep out of children's reach, and storage information at 20° to 25°C. The tablets are for oral use, and the manufacturer is mentioned as Dr. Reddy's. The National Drug Code (NDC) for the tablets is 43506-480-79.*

FDA Label Image

Carton2_90mg (Carton2 90mg)

Each tablet contains ticagrelor 90 mg. It is important to store this medication at a temperature between 20° to 25°C. Remember to keep all medications out of the reach of children. This product is a bulk package and not intended for dispensing. For dosage information, refer to the package insert. *

FDA Label Image

Container90mg (Container90mg)

FDA Label Image

Figure1 (Figure1)

This document appears to show statistical data related to patents and events, possibly in a research or pharmaceutical setting. It includes percentages and numbers related to different timeframes and activities. The text seems to refer to days from the first study drug dose and potentially demonstrates a comparison of events over time. The information may be part of a study or report analyzing the impact of certain factors on the study subjects.*

FDA Label Image

Figure10 (Figure10)

FDA Label Image

Figure11 (Figure11)

FDA Label Image

Figure12 (Figure12)

FDA Label Image

Figure13 (Figure13)

FDA Label Image

Figure14 (Figure14)

FDA Label Image

Figure15 (Figure15)

FDA Label Image

Figure16 (Figure16)

FDA Label Image

Figure17 (Figure17)

FDA Label Image

Figure18 (Figure18)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

This text provides information on the mean effect and 90% confidence interval for the intrinsic factors affecting Ticagrelor AR-C124910XX recommendation. It includes details such as age groups, gender, ethnicity, renal disease status, and hepatic impairment, along with recommendations for dose adjustment based on these factors. The data may be used to guide dosage decisions for Ticagrelor based on individual characteristics.*

FDA Label Image

Figure8 (Figure8)

FDA Label Image

Figure9 (Figure9)

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure1 (Structure1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.